Children over 4 years of age and adolescents
Ulcers infected by a bacteria called “Helicobacter pylori”. If your child has this disease, it is possible that your doctor will prescribe antibiotics to treat the infection and allow the ulcer to heal.
Do not take Omeprazol Tarbis Farma:
If you are unsure, speak with your doctor or pharmacist before taking Omeprazol Tarbis Farma.
Warnings and precautions
When taking omeprazole, inflammation of the kidneys may occur. Symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. Inform your doctor of these symptoms.
Consult your doctor or pharmacist before starting to take Omeprazol Tarbis Farma.
Omeprazol Tarbis Farma may mask symptoms of other diseases.Therefore, if you experience any of the following symptoms before starting to take Omeprazol Tarbis Farma or during treatment, consult your doctor immediately:
If you take Omeprazol Tarbis Farma for a long period (more than 1 year), your doctor will likely perform regular check-ups. Inform your doctor of any new or unusual symptoms and circumstances whenever you visit.
Use of Omeprazol Tarbis Farma with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. Omeprazol Tarbis Farma may affect the mechanism of action of some medications and some medications may affect Omeprazol Tarbis Farma.
Do not take Omeprazol Tarbis Farma if you are taking a medication that containsnelfinavir(used to treat HIV infection).
Inform your doctor or pharmacist if you are taking any of the following medications:
If your doctor has prescribed you the antibiotics amoxicillin and clarithromycin to treat ulcers caused byHelicobacter pyloriinfection, it is very important to inform your doctor of any other medications you are taking.
Taking Omeprazol Tarbis Farma with food and drinks
You can take your capsules with food or on an empty stomach.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Your doctor will decide if you can take Omeprazol Tarbis Farma if you are breastfeeding.
Driving and operating machinery
Omeprazol Tarbis Farma is unlikely to affect your ability to drive or use tools or machines. However, side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or use machines.
Omeprazol Tarbis Farma contains saccharose
This medication contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and age.
The recommended dose is:
Adults:
Treatment of symptoms of GERD, such asheartburn and acid regurgitation:
Treatment ofulcers of the upper part of the intestine(duodenal ulcer):
Treatment ofstomach ulcers(gastric ulcer):
Preventionof the reappearanceofstomach and duodenal ulcers:
Treatment of stomach and duodenal ulcers caused byNSAIDs(nonsteroidal anti-inflammatory drugs):
Prevention of stomach and duodenal ulcersduring the administration ofNSAIDs:
Treatment ofulcers causedby the infectionbyHelicobacter pyloriandprevention of their reappearance:
Treatment of excess acid in the stomach caused by atumor in the pancreas (Zollinger-Ellison syndrome):
Useinchildren
Treatment of symptoms of GERD, such asheartburn and acid regurgitation
Treatment ofulcerscausedby the infectionbyHelicobacter pyloriand prevention of their reappearance:
How to take this medication
What to do if you or your child have trouble swallowing the capsules
If you take more Omeprazole Tarbis Farma than you should
If you have taken more Omeprazole Tarbis Farma than prescribed by your doctor, consult your doctor or pharmacist immediately. You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Omeprazole Tarbis Farma
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to compensate for the missed doses.
Ifyou interruptthetreatmentwithOmeprazoleTarbisFarma
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following rare but serious side effects, stop taking Omeprazol Tarbis Farma and consult your doctor immediately:
Side effects may occur with certain frequencies, which are defined as follows:
Very common: | Affect more than 1 in 10 patients. |
Common: | Affect 1 in 100 to 10 patients. |
Uncommon: | Affect 1 in 100 to 1 in 1,000 patients. |
Rare: | Affect 1 in 10,000 to 1 in 100,000 patients. |
Very rare: | Affect fewer than 1 in 10,000 patients. |
Unknown: | Cannot be determined from available data. |
Other side effects are:
Common side effects
Uncommon side effects
Rare side effects
Very rare side effects
Side effects of unknown frequency
In very rare cases, Omeprazol Tarbis Farma may affect white blood cells in the blood and cause immunodeficiency. If you experience an infection with symptoms such as fever with a severely deteriorated general condition or fever with local infection symptoms, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential to provide information about the medication you are taking at that time.
Do not worry about this list of possible side effects. You may not experience any of them. If you consider any of the side effects you experience to be severe or if you experience any side effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es.
By reporting side effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store below 30°C.
Keep thecontainerperfectly closed to protect it from moisture.
Medicinesshould not be throwninto the drainsorinto the trash.Deposit thepackagingandthemedicinesthat you do not need at theSIGREPoint of the pharmacy.In case of doubt, ask your pharmacist how to dispose of the packaging and the medicines that you do not need.By doing so, you will help protect the environment.
Composition of Omeprazol Tarbis Farma
The gelatin capsule is composed of: gelatin, titanium dioxide (E-171), quinoline yellow (E-104), erythrosine (E-127), iron oxide red (E-172), and water.
Printing ink:Shellac, propylene glycol, sodium hydroxide, polyvinylpyrrolidone, titanium dioxide (E171).
Appearance of the product and contents of the packaging
Omeprazol Tarbis Farma10 mg is presented in the form of hard, gastro-resistant capsules with a yellow-orange body marked with a “10” and a red cap marked with “O” containing white-beige microgranules of Omeprazole.
Packaging sizes:
Packages in blisters of 14 and 28 gastro-resistant capsules.
Packages in HDPE bottles of 14 and 28 gastro-resistant capsules.
Only some packaging sizes may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Tarbis Farma, S.L.
Gran Vía Carlos III, 94
08028 – Barcelona (Spain)
Responsible for manufacturing
Ferrer Internacional, S.A.
Joan Buscallá, 1-9
08173 - Sant Cugat del Vallés (Barcelona)
or
Teva Pharma, S.L.U.
Polígono Malpica C/C, 4
50016 Zaragoza
Last review date of this leaflet:March 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.